[go: up one dir, main page]

AU2001288284A1 - 14189, a human kinase and uses thereof - Google Patents

14189, a human kinase and uses thereof

Info

Publication number
AU2001288284A1
AU2001288284A1 AU2001288284A AU8828401A AU2001288284A1 AU 2001288284 A1 AU2001288284 A1 AU 2001288284A1 AU 2001288284 A AU2001288284 A AU 2001288284A AU 8828401 A AU8828401 A AU 8828401A AU 2001288284 A1 AU2001288284 A1 AU 2001288284A1
Authority
AU
Australia
Prior art keywords
kinase
nucleic acid
expression vectors
acid molecule
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288284A
Inventor
Martin R. Hodge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2001288284A1 publication Critical patent/AU2001288284A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A novel human kinase protein and nucleic acid molecule are disclosed. In addition to the isolated kinase protein, the invention further provides isolated kinase fusion proteins, antigenic peptides, and anti-kinase antibodies. The invention also provides kinase nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a kinase gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.
AU2001288284A 2000-08-18 2001-08-17 14189, a human kinase and uses thereof Abandoned AU2001288284A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/641,690 US6759221B1 (en) 2000-08-18 2000-08-18 14189, a novel human kinase and uses thereof
US09/641,690 2000-08-18
PCT/US2001/025748 WO2002016563A2 (en) 2000-08-18 2001-08-17 14189, a human kinase and uses thereof

Publications (1)

Publication Number Publication Date
AU2001288284A1 true AU2001288284A1 (en) 2002-03-04

Family

ID=24573460

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288284A Abandoned AU2001288284A1 (en) 2000-08-18 2001-08-17 14189, a human kinase and uses thereof

Country Status (7)

Country Link
US (3) US6759221B1 (en)
EP (1) EP1356040B1 (en)
AT (1) ATE435285T1 (en)
AU (1) AU2001288284A1 (en)
DE (1) DE60139153D1 (en)
ES (1) ES2327903T3 (en)
WO (1) WO2002016563A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003371A2 (en) * 2003-06-17 2005-01-13 University Of Virginia Patent Foundation Erk7 and erk8, novel diagnostic markers for cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003501038A (en) 1999-05-28 2003-01-14 スージェン・インコーポレーテッド Protein kinase
US6656698B1 (en) * 1999-06-30 2003-12-02 Millennium Pharmaceuticals, Inc. 12832, a novel human kinase-like molecule and uses thereof
EP1240194A2 (en) 1999-11-24 2002-09-18 Sugen, Inc. Novel human protein kinases and protein kinase-like enzymes
EP1261721A1 (en) 2000-03-08 2002-12-04 MERCK PATENT GmbH Human extracellular signal regulated kinases
US6416990B2 (en) 2000-06-06 2002-07-09 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
US6413756B2 (en) * 2000-06-06 2002-07-02 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU2001288612A1 (en) 2000-08-31 2002-03-13 Incyte Genomics, Inc. Human kinases

Also Published As

Publication number Publication date
US6759221B1 (en) 2004-07-06
WO2002016563A2 (en) 2002-02-28
US20040146939A1 (en) 2004-07-29
ES2327903T3 (en) 2009-11-05
US20110110915A1 (en) 2011-05-12
EP1356040B1 (en) 2009-07-01
ATE435285T1 (en) 2009-07-15
DE60139153D1 (en) 2009-08-13
EP1356040A2 (en) 2003-10-29
WO2002016563A3 (en) 2002-10-31
US7759085B2 (en) 2010-07-20

Similar Documents

Publication Publication Date Title
AU3217100A (en) Methods of use of a novel lysyl oxidase-related protein
WO2000052047A3 (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
WO2002044354A3 (en) Molecules of the card-related protein family and uses thereof
WO2000019988A8 (en) NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
AU6517400A (en) 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
AU2001280639A1 (en) 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor
AU2001249649A1 (en) 16836, a novel human phospholipase c family member and uses thereof
WO2001094412A3 (en) 56201, a novel human sodium ion channel family member and uses thereof
WO2001090365A3 (en) Human protein kinase '13305' and uses therefor
WO2001064894A3 (en) Human phospholipid scramblase-like molecules and uses thereof
AU2001288284A1 (en) 14189, a human kinase and uses thereof
WO2001000879A8 (en) Novel kinases and uses thereof
WO2001081588A3 (en) 2246, novel protein kinase molecules and uses therefor
WO2001073050A3 (en) 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
WO2001064919A3 (en) 18036, a novel calpain-like protease and uses thereof
WO2002081516A8 (en) Narc10 and narc16, programmed cell death-associated molecules and uses thereof
AU2002352068A1 (en) 2150, a human protein kinase family member and uses therefor
AU2002234132A1 (en) 13245, a novel human myotonic dystrophy type protein kinase and uses therefor
WO2001068806A3 (en) 26934, a novel cytidine deaminase-like molecule and uses thereof
WO2003035840A3 (en) 69583 and 85924, novel human protein kinase family members and uses therefor
AU2002359572A1 (en) 15603, a human ion channel family member
WO2002010401A3 (en) 18431 and 32374, human protein kinase family members and uses therefor
WO2001081558A3 (en) 13295 novel protein kinase molecules and uses therefor
WO2001064910A3 (en) Atpase-like molecule and uses thereof
WO2002002761A3 (en) 57658, a human uridine kinase and uses thereof